AKYA

Akoya BioSciences
AKYA

Overview Fund Activity
Delisted

AKYA was delisted on the 7th of July, 2025.

Back to rankings

63 hedge funds and large institutions have $109M invested in Akoya BioSciences in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-10
Holders Change %
-13.7%
% of All Funds
1.01%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
6
Increased
25
Reduced
21
Closed
16
Calls
$277K
Puts
$103K
Net Calls
+$174K
Net Calls Change
-$35K

Top Buyers

1
BWLSA
Blue Water Life Science Advisors
California
+$2.05M
2
ACM
Altium Capital Management
New York
+$1.39M
3
EIM
Essex Investment Management
Massachusetts
+$881K
4
Millennium Management
Millennium Management
New York
+$782K
5
CS
Candriam SCA
Luxembourg
+$708K

Top Sellers

1
HEC
Hudson Executive Capital
New York
-$3.91M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$2.73M
3
Bank of America
Bank of America
North Carolina
-$2.15M
4
CEI
Clark Estates Inc
New York
-$1.63M
5
RI
RTW Investments
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Shares
Change %
GWS
76
Glassman Wealth Services
Virginia
– -$134 -14 Closed
CS
77
Credit Suisse
Switzerland
– -$10 -1 Closed
1 2 3
4